Search results for "insufficiency"

showing 10 items of 506 documents

Outcome and attitudes toward home tracheostomy ventilation of consecutive patients: a 10-year experience.

2008

Summary Objectives To describe survival, predictors of long-term outcome and attitudes in patients treated at home by tracheostomy-intermittent positive-pressure ventilation (TIPPV) for respiratory failure during a 10-year period (1995–2004). Methods Seventy-seven consecutive patients were treated by TIPPV at home. Patients were divided into three groups: neuromuscular, pulmonary, and non-pulmonary patients. Effects of TIPPV on survival, factors influencing outcome after TIPPV, and attitudes of patients and caregivers regarding mechanical ventilation were studied. Results Forty-one patients (53%) were neuromuscular, 19 (25%) were affected by pulmonary diseases, and 17 (22%) by non-pulmonary…

Artificial ventilationPulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtySurvivalHome Nursingmedicine.medical_treatmentRespiratory failureIntermittent Positive-Pressure VentilationPulmonary Disease Chronic ObstructiveTracheotomyTracheostomyInternal medicinemedicineCOPDHumansProspective StudiesProspective cohort studySurvival rateAgedMechanical ventilationAged 80 and overCOPDbusiness.industryTracheostomy mechanical ventilationRespiratory diseaseAmyotrophic Lateral SclerosisNeuromuscular DiseasesMiddle Agedmedicine.diseaseRespiration ArtificialSurgerySurvival RateCaregiversRespiratory failureFemaleALSbusinessRespiratory InsufficiencyAttitude to HealthRespiratory medicine
researchProduct

Glycated albumin as a glycaemic marker in patients with advanced chronic kidney disease and anaemia: a preliminary report.

2019

BACKGROUND: The association between glycated albumin (GA) and glycaemic status has not been fully described in patients with advanced chronic kidney disease (CKD) in relation to anaemia. The aim of this study was to evaluate the relationship between GA and fasting plasma glucose (FPG) and HbA1c in patients with advanced CKD and to evaluate the influence of anaemia in such relationship. MATERIALS AND METHODS: Patients with CKD stage 4 or 5 were included in the study. eGFR was calculated by the CKD-EPI creatinine equation. Plasma GA was measured by an enzymatic method. RESULTS: Eighty-one patients were included in the study, 46 (57%) were males; the mean age was 67 ± 14 years. HbA1c was corre…

Blood GlucoseGlycation End Products AdvancedMalemedicine.medical_specialtyClinical Biochemistry030209 endocrinology & metabolism030204 cardiovascular system & hematologyGastroenterologyrenal insufficiency03 medical and health sciences0302 clinical medicineGlycated albuminPreliminary reportInternal medicinemedicineHumansIn patientGlycated Serum AlbuminRenal Insufficiency ChronicSerum AlbuminAgedGlycated Hemoglobinanaemiabusiness.industryAnemiaGeneral MedicineFastingmedicine.diseaseglycated haemoglobin ARegression AnalysisFemalebusinessBiomarkersKidney diseaseScandinavian journal of clinical and laboratory investigation
researchProduct

Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month re…

2018

OBJECTIVE Dual-release hydrocortisone (DR-HC) provides physiological cortisol exposure, leading to an improvement of anthropometric and metabolic parameters. The aim of the study was to evaluate the effects of DR-HC on insulin secretion and sensitivity and cardiometabolic risk, indirectly expressed by the visceral adiposity index (VAI). DESIGN AND PATIENTS Retrospective analysis of 49 patients, 13 with primary and 36 with secondary adrenal insufficiency (AI), respectively, on conventional glucocorticoid treatment at baseline and switched to DR-HC for 36 months. Overall, 24 patients had AI-pre-diabetes (impaired fasting glucose, impaired glucose tolerance and the combination), and 25 had AI-…

Blood Glucoseinsulin secretionmedicine.medical_specialtyWaistHydrocortisoneEndocrinology Diabetes and Metabolism030209 endocrinology & metabolism030204 cardiovascular system & hematologySettore MED/13 - EndocrinologiaImpaired glucose tolerancePrediabetic State03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusGlucose IntolerancemedicineAdrenal insufficiencyHumansplenadrenPrediabetesGlucocorticoidsHydrocortisoneRetrospective Studiesbusiness.industryAdrenal insufficiency; diabetes; dual-release hydrocortisone; insulin secretion; plenadren; Endocrinology Diabetes and MetabolismFastingImpaired fasting glucosemedicine.diseaseEndocrinologydiabetedual-release hydrocortisoneInsulin ResistanceWaist CircumferencebusinessGlucocorticoidmedicine.drugAdrenal InsufficiencyClinical endocrinology
researchProduct

Irisinemia: A Novel Concept to Coin in Clinical Medicine?

2013

Skeletal muscle can express and release substances such as cytokines or other peptides capable of modulating metabolic processes. These cytokines, named ‘myokines', function as hormones either locally within the muscle or by targeting distant organs. A novel peptidic myokine named ‘irisin' has been recently identified. It has been noted that circulating irisin levels are lower in type 2 diabetes (T2D) compared with nondiabetic controls as well as in patients with chronic kidney disease. In addition, a negative correlation between the hemoglobin A1c (HbA1c) and circulating levels of irisin has been also observed. Thus, the blood concentration of irisin may reflect the metabolic status of pat…

Blood Glucosemedicine.medical_specialtyendocrine system diseasesMedicine (miscellaneous)Type 2 diabetesMetabolic DiseasesDiabetes mellitusInternal medicineMyokineHumansMedicineObesityRenal Insufficiency ChronicMuscle SkeletalNutrition and Dieteticsbusiness.industrynutritional and metabolic diseasesSkeletal musclemedicine.diseaseObesityFibronectinsMetabolism disorderEndocrinologymedicine.anatomical_structureDiabetes Mellitus Type 2ImmunologyCytokinesbusinessHormoneKidney diseaseAnnals of Nutrition and Metabolism
researchProduct

Haemostasis in chronic kidney disease

2013

The coagulation system has gained much interest again as new anticoagulatory substances have been introduced into clinical practice. Especially patients with renal failure are likely candidates for such a therapy as they often experience significant comorbidity including cardiovascular diseases that require anticoagulation. Patients with renal failure on new anticoagulants have experienced excessive bleeding which can be related to a changed pharmacokinetic profile of the compounds. However, the coagulation system itself, even without any interference with coagulation modifying drugs, is already profoundly changed during renal failure. Coagulation disorders with either episodes of severe bl…

Blood PlateletsExcessive Bleedingmedicine.medical_specialtymedicine.medical_treatmentHemorrhageThrombophiliaInternal medicinemedicineHumansRenal InsufficiencyRenal Insufficiency ChronicHemostatic functionBlood CoagulationCoagulation DisorderHemostasisTransplantationbusiness.industryAnticoagulantsThrombosisBlood Coagulation Disordersmedicine.diseaseThrombosisSurgeryOxidative StressCoagulationNephrologyAntibodies AntiphospholipidCardiologyEndothelium VascularHemodialysisbusinessKidney diseaseNephrology Dialysis Transplantation
researchProduct

Management of secondary hyperparathyroidism in uremic patients : the role of the new vitamin D analogs

2007

Secondary hyperparathyroidism - a common comorbid condition in patients with chronic renal insufficiency - is considered a consequence of critical determinants such as hypocalcemia, phosphate retention and reduced levels of calcitriol production. In this complex mechanism, the skeletal apparatus and the nonskeletal targets such as vascular and heart valves are often involved, thus explaining the increased risk of cardiovascular morbidity and mortality of uremic patients. In this review we will focus on the major role played by Calcitriol deficiency as a trigger of secondary hyperparathyroidism and the crucial need for obiquitous vitamin D receptor activation in order to have an optimal PTH …

Bone Density Conservation AgentsCalcitriolHypocalcemiaErgocalciferolsHumansReceptors CalcitriolHyperparathyroidism SecondaryRenal Insufficiency ChronicVitamin DVitamin D DeficiencyPhosphatesUremia
researchProduct

Sudden sensorineural hearing loss as prodromal symptom of anterior inferior cerebellar artery infarction.

2011

Sudden sensorineural hearing loss is a clinical condition characterized by a sudden onset of unilateral or bilateral hearing loss. In recent years sudden deafness has been frequently described in association with anterior inferior cerebellar artery (AICA) infarction generally presenting along with other brainstem and cerebellar signs such as ataxia, dysmetria and peripheral facial palsy. The authors report a rare clinical case of a 53-year-old man who suddenly developed hearing loss and tinnitus without any brainstem or cerebellar signs. Computed tomography of his brain was normal, and the audiological results localized the lesion causing deafness to the inner ear. Surprisingly, magnetic re…

Brain InfarctionMalemedicine.medical_specialtyAnterior inferior cerebellar artery infarctionAtaxiaHearing lossHearing Loss SensorineuralInfarctionLesionSudden deafneCerebellar DiseasesInternal auditory arteryDysmetriamedicine.arteryInternal medicineCerebellumInner earotorhinolaryngologic diseasesmedicineVertebrobasilar InsufficiencyHumansbusiness.industrySettore MED/37 - NeuroradiologiaMiddle Agedmedicine.diseaseMagnetic Resonance ImagingSudden deafness; Anterior inferior cerebellar artery infarction; Internal auditory artery; Inner earSettore MED/32 - AudiologiaSurgeryAnterior inferior cerebellar arterymedicine.anatomical_structureOtorhinolaryngologyEar InnerAcute DiseaseCardiologySettore MED/26 - Neurologiamedicine.symptomCerebellar arterybusinessTinnitusORL; journal for oto-rhino-laryngology and its related specialties
researchProduct

Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a pr…

2013

PURPOSE To assess the efficacy of gonadotropin-releasing hormone agonist (GnRHa) in preventing chemotherapy-induced ovarian failure in patients treated for Hodgkin or non-Hodgkin lymphoma within the setting of a multicenter, randomized, prospective trial. PATIENTS AND METHODS Patients age 18 to 45 years were randomly assigned to receive either the GnRHa triptorelin plus norethisterone (GnRHa group) or norethisterone alone (control group) concomitantly with alkylating agents containing chemotherapy. The primary end point was the premature ovarian failure (POF) rate (follicle-stimulating hormone [FSH] ≥ 40 IU/L) after 1 year of follow-up. Results Eighty-four of 129 randomly assigned patients …

Cancer ResearchTime FactorsLymphomamedicine.medical_treatmentGonadotropin-Releasing Hormone -- agonistsPrimary Ovarian InsufficiencyTriptorelin Pamoate -- therapeutic uselaw.inventionGonadotropin-Releasing HormoneGynécologieRandomized controlled triallawAntineoplastic Combined Chemotherapy ProtocolsClinical endpointBiological Markers -- bloodNorethindrone -- therapeutic useProspective StudiesTreatment FailureProspective cohort studyTriptorelin PamoateEstradiolLymphoma Non-HodgkinLymphoma -- drug therapyMiddle AgedTriptorelinHodgkin DiseasePremature ovarian failureLuteolytic AgentsOncologyHodgkin Disease -- drug therapyDrug Therapy CombinationFemaleEstradiol -- bloodmedicine.drugAdultAntineoplastic Combined Chemotherapy Protocols -- administration & dosage -- adverse effectsmedicine.medical_specialtyNorethisteronemedicine.drug_classUrologyFollicle Stimulating Hormone -- bloodGonadotropin-releasing hormone agonistmedicineHumansGynecologyChemotherapybusiness.industrymedicine.diseaseLuteolytic Agents -- therapeutic useCancérologieLymphoma Non-Hodgkin -- drug therapyPremenopausePrimary Ovarian Insufficiency -- blood -- chemically induced -- prevention & controlFollicle Stimulating HormoneNorethindronebusinessBiomarkersFollow-Up Studies
researchProduct

Computed tomography imaging needs for novel transcatheter tricuspid valve repair and replacement therapies

2020

Abstract Transcatheter tricuspid valve therapies are an emerging field in structural heart interventions due to the rising number of patients with severe tricuspid regurgitation and the high risk for surgical treatment. Computed tomography (CT) allows exact measurements of the annular plane, evaluation of adjacent structures, assessment of the access route, and can also be used to identify optimal fluoroscopic projection planes to enhance periprocedural imaging. This review provides an overview of current transcatheter tricuspid valve repair and replacement therapies and to what extent CT can support these interventions.

Cardiac Catheterizationmedicine.medical_specialtyComputed tomographyRegurgitation (circulation)030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineTricuspid Valve InsufficiencyMedical imagingHumansMedicineRadiology Nuclear Medicine and imagingcardiovascular diseases030212 general & internal medicineTRICUSPID VALVE REPAIRSurgical treatmentHeart Valve Prosthesis ImplantationTricuspid valveAccess routemedicine.diagnostic_testbusiness.industryGeneral MedicineTricuspid Valve InsufficiencyTreatment Outcomemedicine.anatomical_structureHeart Valve Prosthesiscardiovascular systemTricuspid ValveRadiologyTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal - Cardiovascular Imaging
researchProduct

Centre procedural volume and adverse in‐hospital outcomes in patients undergoing percutaneous transvenous edge‐to‐edge mitral valve repair usingMitra…

2021

AIMS The number of transcatheter mitral valve repair (TMVr) procedures has increased substantially during the last years. A better understanding of the relationship between hospital volume of transcatheter transvenous mitral valve repairs using MitraClip® and patient outcomes may provide information for future policy decisions to improve patient management. METHODS AND RESULTS We analysed patient characteristics and in-hospital outcomes for all TMVr procedures using MitraClip® performed in Germany from 2011 to 2017. Hospitals were stratified according to centre volumes and patients were compared for baseline characteristics and adverse in-hospital events. Overall, 24 709 inpatients were tre…

Cardiac Catheterizationmedicine.medical_specialtyPercutaneousmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineGermanyMitral valvemedicineHumansHeart FailureHeart Valve Prosthesis ImplantationMitral regurgitationMitral valve repairbusiness.industryMitraClipMitral Valve InsufficiencyOdds ratiomedicine.diseaseHospitalsConfidence intervalSurgeryPulmonary embolismTreatment Outcomemedicine.anatomical_structureHeart Valve ProsthesisMitral ValveCardiology and Cardiovascular MedicinebusinessEuropean Journal of Heart Failure
researchProduct